pLenti6.3/TO/V5-DEST-IGFBP2
(Plasmid
#191006)
-
PurposeLentiviral expression vector for IGFBP2
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 191006 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti6.3/TO/V5-DEST
-
Backbone manufacturerInvitrogen (Life Technologies)
- Backbone size w/o insert (bp) 9351
- Total vector size (bp) 8689
-
Vector typeLentiviral
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameInsulin-Like Growth Factor Binding Protein 2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)987
-
GenBank ID3485
-
Entrez GeneIGFBP2 (a.k.a. IBP2, IGF-BP53)
- Promoter CMV
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer CMV_F
- 3′ sequencing primer WPRE_R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti6.3/TO/V5-DEST-IGFBP2 was a gift from Johanna Ivaska (Addgene plasmid # 191006 ; http://n2t.net/addgene:191006 ; RRID:Addgene_191006) -
For your References section:
IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Conway JRW, Dinc DD, Follain G, Paavolainen O, Kaivola J, Bostrom P, Hartiala P, Peuhu E, Ivaska J. Sci Adv. 2023 Jul 14;9(28):eadg1840. doi: 10.1126/sciadv.adg1840. Epub 2023 Jul 12. 10.1126/sciadv.adg1840 PubMed 37436978